GlassScriptPhysician profile
Aslam H Khaja
NPI 1003014457
$1,205.55
in general payments reported to CMS, 2019-2025
10 companies · $56.40 in 2025
The $56.40 reported for 2025 was less than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $88.40 · 2021: $324 · 2022: $118 · 2023: $165 · 2024: $152 · 2025: $56.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $373.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tg Therapeutics, INC. | $220.99 | 2023-2025 | |
| Ucb, INC. | $126.53 | 2019 | |
| Argenx US, INC. | $125.00 | 2024 | Vyvgart Hytrulo |
| Medtronic, INC. | $118.02 | 2022 | |
| Boston Scientific Corporation | $115.66 | 2021 | |
| Lundbeck LLC | $107.42 | 2019-2024 | Vyepti |
| Biohaven Pharmaceuticals, INC. | $107.06 | 2021 | |
| Abbvie INC. | $100.78 | 2021 | |
| Medtronic USA, INC. | $95.69 | 2019 | |
| Novartis Pharmaceuticals Corporation | $88.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aslam Khaja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.